Kailera IPO Is Biggest So Far In 2026, May Become Biopharma’s Largest In The US

At Least Three More First-Time Offerings Pending

Stock market bull run
At least three more companies may soon go public, taking advantage of the recent biopharma bull market (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business